FAB-144
FAB-144 is a type of synthetic cannabinoid, which is a group of chemical compounds that mimic the effects of cannabinoids naturally produced by the cannabis plant. FAB-144 was first identified in Japan in 2013, and it is sold as a designer drug.
Chemistry[edit]
FAB-144 is a derivative of indazole, a type of organic compound. It is specifically an indazole-3-carboxamide, which means it has a carboxamide group attached to the third carbon atom of the indazole ring. The full chemical name of FAB-144 is N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide.
Effects[edit]
The effects of FAB-144 are similar to those of other synthetic cannabinoids and can include euphoria, relaxation, and altered perception. However, because it is a research chemical, the full range of its effects is not well understood. It is known to be a potent agonist of the CB1 receptor, which is found in the brain and is responsible for the psychoactive effects of cannabis.
Legal status[edit]
FAB-144 is illegal in many countries, including the United States, where it is classified as a Schedule I drug under the Controlled Substances Act. It is also banned in many European countries under the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
Health risks[edit]
As with other synthetic cannabinoids, FAB-144 can have serious health risks. These can include psychosis, seizures, and even death. Because it is often sold as a legal alternative to cannabis, users may not be aware of these risks.
See also[edit]
- Synthetic cannabinoids
- Indazole
- Cannabinoids
- Cannabis
- Designer drug
- CB1 receptor
- Controlled Substances Act
- European Monitoring Centre for Drugs and Drug Addiction
 | This medical article is a stub. You can help WikiMD by expanding the page. |
-
FAB-144
